These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11499826)

  • 1. Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate.
    Tournadre A; D'Incan M; Dubost JJ; Franck F; Déchelotte P; Souteyrand P; Soubrier M
    Mayo Clin Proc; 2001 Aug; 76(8):845-8. PubMed ID: 11499826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
    Maruani A; Wierzbicka E; Machet MC; Abdallah-Lotf M; de Muret A; Machet L
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S69-71. PubMed ID: 17938029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
    Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; Molinié V; Dubertret L
    Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus?
    Starkebaum G
    J Rheumatol; 2001 Dec; 28(12):2573-5. PubMed ID: 11764198
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.
    Yamada K; Oshiro Y; Okamura S; Fujisaki T; Kondo S; Nakayama Y; Suematsu E; Tamura K; Takeshita M
    Histopathology; 2015 Jul; 67(1):70-80. PubMed ID: 25429725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
    Miyazaki T; Fujimaki K; Shirasugi Y; Yoshiba F; Ohsaka M; Miyazaki K; Yamazaki E; Sakai R; Tamaru J; Kishi K; Kanamori H; Higashihara M; Hotta T; Ishigatsubo Y
    Am J Hematol; 2007 Dec; 82(12):1106-9. PubMed ID: 17654684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis.
    Migita K; Miyashita T; Mijin T; Sakito S; Kurohama H; Ito M; Toda K; Tsustumi K; Baba H; Izumi Y; Kawakami A; Niino D; Ohshima K
    Mod Rheumatol; 2013 Jul; 23(4):832-6. PubMed ID: 22825547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis: a case report and review of literature.
    Sekiguchi Y; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Ikeda K; Sekikawa I; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2015; 8(2):2090-102. PubMed ID: 25973110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
    Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T
    Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis].
    Pastor-Nieto MA; Kilmurray LG; López-Chumillas A; O'Valle F; García-Del Moral R; Puig AM; Bautista P
    Actas Dermosifiliogr; 2009 Mar; 100(2):142-6. PubMed ID: 19445880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous Epstein-Barr virus-associated B-cell lymphoma arising at the site of subcutaneous injections of methotrexate.
    Giard C; Avenel-Audran M; Croué A; Verret JL; Martin L
    J Clin Oncol; 2010 Dec; 28(34):e717-8. PubMed ID: 20823409
    [No Abstract]   [Full Text] [Related]  

  • 14. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.
    Kamel OW; van de Rijn M; Weiss LM; Del Zoppo GJ; Hench PK; Robbins BA; Montgomery PG; Warnke RA; Dorfman RF
    N Engl J Med; 1993 May; 328(18):1317-21. PubMed ID: 8385742
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.
    Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D
    J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-positive oral ulceration simulating Hodgkin lymphoma in a patient treated with methotrexate: case report and review of the literature.
    Naidu A; Kessler HP; Pavelka MA
    J Oral Maxillofac Surg; 2014 Apr; 72(4):724-9. PubMed ID: 24246254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
    Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
    Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
    Park S; Lee DY; Kim WS; Ko YH
    Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
    Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
    J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoma with regression after methotrexate withdrawal in a patient with rheumatoid arthritis. Role for the Epstein-Barr virus.
    Le Goff P; Chicault P; Saraux A; Baron D; Valls-Bellec I; Leroy JP
    Rev Rhum Engl Ed; 1998 Apr; 65(4):283-6. PubMed ID: 9599798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.